Test stem-cell based treatment for adults with ARDS
Part of Lungs & breathing clinical trials.
This Phase 3 study tests whether an allogeneic “MesenCure” therapy can improve outcomes in adults with ARDS (a serious lung injury). It aims to see if the treatment helps patients recover better than standard care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can consent to the study before any study procedures
- You are 18–80 years old
- You have ARDS confirmed by the study team
- Your oxygen level is low (RA-oxygen saturation ≤93%) and/or imaging shows COVID-related lung changes
- Your blood pressure is relatively stable (top <180 and bottom <110)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 trial studies an “extracellular vesicle” treatment in people with moderate to severe ARDS, a serious lung breathing problem. The goal is to see whether the treatment can improve outcomes compared with standard care.
This trial is testing new treatments for people with ARDS, a serious lung condition. The goal is to find therapies that help patients breathe better and recover faster. If you or a loved one has ARDS, this study may offer access to experimental treatments.
This trial tests whether human umbilical cord mesenchymal stem cells given through an IV can help people with severe ARDS. It aims to see if the treatment is safe and if it can improve breathing and recovery.
This Phase 2 trial tests GEn-1124 to see if it can improve outcomes in people with acute respiratory distress syndrome (ARDS). You may be eligible if the study drug can be started very soon after ARDS is diagnosed and if you meet the safety and health requirements.
This trial tests whether umbilical cord stem cells are safe for people with mild to moderate ARDS. It aims to see if these cells can help reduce lung inflammation and improve breathing.
This trial tests whether an injection of stem cells from umbilical cords can help people with severe ARDS (a type of lung failure) recover faster. It is for those who have not improved after standard treatment and whose ARDS is caused by an infection (not COVID-19).
Hear when a new ARDS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.